search the site
About Us
Career Center
Store
Contact Us
Donate
Login
American Society of Addiction Medicine
Menu
Advocacy
Advocacy Main Page
Advocacy Committees & Councils
Advocacy News
Advocacy Toolkits
Coalitions
Legislative Tracker
Public Policy Statements
Take Action
ASAM Hill Day 2019
Education
CME Events
e-Learning Center
Live & Online CME
Educational Resources
Certification Hub
Joint Provider CME
Membership
Join ASAM Today
Member Types & Dues
Benefits
Get Involved
Designations
Associate Membership
Students, Residents & Fellows
Awards & Scholarships
State Chapters
Why I Treat Addiction
National Addiction Treatment Week
Resources
The ASAM Criteria
Quality
Publications
Definition of Addiction
Practice Management
Additional Resources
Addiction Medicine Fellows
CME Events
PUBLIC POLICY STATEMENTS
Policy Categories
Featured Policies
All Policies
White Papers
Endorsed Policy Statements
Archives
Children and Addiction
Ethics
Infectious Diseases and Addiction
Insurance Coverage and Payment for Addiction Treatment
Licensed Professionals with Addictive Illness
Marijuana
National Drug Policy
Nicotine
Opioids
Practice of Addiction Medicine
Prevention
Public Health
Recovery
Women and Addiction
Featured Policy Statements
Prescription Drug Monitoring Programs (PDMPs)
April 11, 2018
(?)
Marijuana, Cannabinoids and Legalization
September 21, 2015
(?)
Prescription Drug Monitoring Programs (PDMPs)
April 11, 2018
(?)
Morphine Equivalent Units/Morphine Milligram Equivalents
October 8, 2016
(?)
Patient Review and Restriction (PRR) Programs
April 12, 2016
(?)
Marijuana, Cannabinoids and Legalization
September 21, 2015
(?)